Incyte (INCY) Return on Invested Capital (2012 - 2026)
Incyte (INCY) posted Return on Invested Capital of 0.08% for Q1 2026, up 12.88% on a QoQ basis from 0.07% in Q4 2025, and up 8.0% year-over-year from 0.07% in Q1 2025.
Incyte (INCY) Return on Invested Capital (2012 - 2026) Analysis & Trends
Incyte's Return on Invested Capital history runs 14 years deep, the most recent figure standing at 0.08% for Q1 2026.
- Quarterly Return on Invested Capital rose 8.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.08% (up 8.0% YoY) and the FY2025 annual result came in at 0.32%, up 32.0% from the prior year.
- Return on Invested Capital was 0.08% for Q1 2026 at Incyte, up from 0.07% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.08% in Q1 2026 and bottomed at 0.0% in Q3 2024.
- A 5-year average of 0.04% and a median of 0.03% in 2023 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2023 — Return on Invested Capital fell 5 bps — and 2026, when it advanced 8 bps.
- Incyte's Return on Invested Capital stood at 0.03% in 2022, then advanced by 19 bps to 0.03% in 2023, then plunged by 99 bps to 0.0% in 2024, then surged by 16189 bps to 0.07% in 2025, then increased by 13 bps to 0.08% in 2026.
- Business Quant data shows INCY's Return on Invested Capital at 0.08% in Q1 2026, 0.07% in Q4 2025, and 0.07% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 0.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08% |
| Dec 31, 2025 | 0.07% |
| Sep 30, 2025 | 0.07% |
| Jun 30, 2025 | 0.05% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.03% |
| Dec 31, 2023 | 0.03% |
| Sep 30, 2023 | 0.02% |
| Jun 30, 2023 | 0.02% |
| Mar 31, 2023 | 0.02% |
| Dec 31, 2022 | 0.03% |
| Sep 30, 2022 | 0.06% |
| Jun 30, 2022 | 0.07% |
| Mar 31, 2022 | 0.06% |
| Dec 31, 2021 | 0.06% |
| Sep 30, 2021 | 0.04% |
| Jun 30, 2021 | 0.03% |